Pharma & Biotech Mergers & Acquisitions News
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Today's issue
Refine Search
Latest Mergers & Acquisitions News & Features
Generics
Aspire Pharma, a UK-based niche generics business, has announced the acquisition of all assets from Canute Pharma, further expanding its product range. 4 October 2024
Generics
Viatris has announced that the antitrust division of the US Department of Justice (DOJ) has concluded its investigation into Mylan and its former president, Rajiv Malik. 3 July 2024
Generics
An activist investor has renewed its effort to prevent Taro Pharmaceutical from accepting a buyout bid from Sun Pharmaceutical. 24 April 2024
Generics
Generic drugmaker Apotex has reached an agreement to acquire fellow Canada-based Searchlight Pharma. 5 April 2024
Generics
KELIX bio, an emerging markets biopharmaceuticals platform, has been sold to Mubadala Investment Company, an Abu Dhabi investor with over $276 billion in assets under management. 25 March 2024
Generics
Generic drugmaker Aspire Pharma today announced the successful completion of its acquisition of fellow UK-based Cenoté Pharma, in continuation of its strong organic growth. 11 March 2024
Generics
In a bid to focus on growth and innovation, Israeli generics drugmaker Teva Pharmaceutical is to hive off its active pharmaceutical ingredient (API) business. 1 February 2024
Generics
Sun Pharmaceutical Industries of India announced its intention to acquire all outstanding shares of US generics drugmaker Taro Pharmaceutical Industries at a price of $43 per share in cash, the companies announced. 19 January 2024
Generics
Taiwan’s Bora Pharmaceuticals is to acquire Upsher-Smith Laboratories, a US generics manufacturer. 17 January 2024
Generics
South Africa's largest drugmaker Aspen Pharmacare has announced an agreement with newly-independent generics drugmaker Sandoz, related to its Chinese business. 7 December 2023
Generics
Portuguese contract development and manufacturing organization (CDMO) Hovione has acquired the start-up ExtremoChem for an undisclosed amount. 20 November 2023
Generics
The Indian pharma and healthcare sector has witnessed a 298% jump in deals during the third quarter of 2023 compared to the same period last year. 8 November 2023
Generics
A confluence of factors is creating a conducive environment for mergers and acquisitions (M&As) to pick up pace in India. 23 October 2023
Generics
USA-based drugmaker Viatris has announced a series of divestitures as part of a strategy to narrow the company’s focus. 3 October 2023
Generics
Indian drugmaker Glenmark Pharmaceuticals has entered into a definitive agreement with Nirma Limited to divest a 75% stake in its subsidiary, Glenmark Life Sciences Limited (GLS), which focuses on producing active pharmaceutical ingredients (APIs). 22 September 2023
Generics
Shares of Hyderabad, India-headquartered Suven Pharmaceuticals hit a fresh 52-week high on the bourses after the Indian government gave the green signal to foreign direct investment (FDI) of up to $1.15 billion by drug major Cyprus-based Berhyanda. 19 September 2023
Generics
Several international investors and fund managers have expressed an interest in investing in the Indian pharmaceutical and biotechnology sectors, underlining the need to establish a platform to facilitate the transition of global capital flows into the domestic economy. 14 April 2023
Generics
In what could well be India's biggest pharma deal, China's Fosun Pharma-owned Gland Pharma is on the block. A number of private equity firms have been approached, including Baring Private Equity, Bain Capital, Blackstone, Carlyle, and KKR. 19 December 2022
Generics
Generics major Viatris yesterday said it intends to create an ophthalmology franchise by acquiring two companies, Oyster Point Pharma (Nasdaq: OYST) and Famy Life Sciences. 8 November 2022
Generics
Private equity firm SK Capital Partners has entered into a deal to acquire Apotex Pharmaceutical Holdings, a Canada-based generic drugmaker with products across all major therapeutic areas for patients around the world. 29 September 2022
Generics
Adcock Ingram has announced the disposal of its 100% shareholding in Adcock Ingram Healthcare Private Limited, the marketing and selling operation in India, under a definitive agreement to Samara Capital Partners, an India focused private equity firm. 11 April 2016
Generics
China-based Humanwell Healthcare Group and PuraCap Pharmaceutical have entered into a definitive agreement to acquire 100% of privately-held US generic drugs marker Epic Pharma. 8 April 2016
Generics
The Federal Trade Commission has approved a modified final order settling charges that Jordon-headquartered Hikma Pharmaceuticals’ acquisition of the rights to various drug products and related assets from Ben Venue Laboratories was anticompetitive. 1 April 2016
Generics
The European Commission has approved under the EU Merger Regulation the proposed acquisition of the generics business of Ireland-incorporated Allergan by Israel’s Teva Pharmaceutical Industries, subject to conditions. 10 March 2016
Generics
Alvogen has announced the acquisition of specialty generic pharmaceutical company County Line for an undisclosed sum. 7 March 2016
Generics
Hikma Pharmaceuticals will sell the rights and assets for two generic drugs, and relinquish its US marketing rights to a third generic drug, in order to settle US Federal Trade Commission charges that Hikma’s proposed acquisition of Roxane from German family-owned pharma major Boehringer Ingelheim would likely be anticompetitive. 29 February 2016
Generics
The US Federal Trade Commission was seen to flex its muscles on Friday, as it imposed conditions on two proposed M&A deals. 21 February 2016
Generics
Following receipt of new financial performance information from Boehringer Ingelheim, Jordon-based drugmaker Hikma Pharmaceuticals said today that is revising the terms of the acquisition of the family-owned German pharma major’s Roxane Laboratories unit. 10 February 2016
Generics
Gedeon Richter says it has acquired from its partner, Rxmidas Pharmaceuticals Holdings, its outstanding 50% stake in Gedeon Richter Rxmidas Joint Venture Co Ltd following the setting up of a joint venture with an initial 50% share of equity announced in December 2010. 1 February 2016
Generics
India-based Zydus Group, part of Zydus Wellness Ltd, said it has via its animal health unit acquired select brands and the manufacturing operations in Haridwar, India, from US-based Zoetis in a bid to expand its animal health business in India and gain access to manufacturing operations which have also been catering to global markets. 5 January 2016
Generics
Sweden’s Meda AB (STO: MEDAA) said today it has completed the divestment of the manufacturing unit Euromed in Spain to the Riverside Company. 31 December 2015
Generics
Ireland-incorporated Perrigo has said it will acquire a portfolio of generic dosage forms and strengths of Retin-A (tretinoin) from Matawan Pharmaceuticals, a subsidiary of Rouses Point Pharmaceuticals. 18 December 2015
Generics
UCB says it has completed its previously-announced transaction providing for the sale of its US specialty generics subsidiary, Kremers Urban Pharmaceuticals (KU), to Lannett Company. 27 November 2015
Generics
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that the $8 billion merger between Endo International and privately-held Par Pharmaceuticals would likely be anticompetitive. 19 November 2015
Generics
The majority of Ireland-based Perrigo shareholders have rejected Mylan's hostile tender offer. 13 November 2015
Generics
Netherlands-incorporated drugmaker Mylan yesterday received tentative approval from the US Federal Trade Commission for the company's proposed acquisition of Perrigo subject to Mylan's divestiture of certain products following the consummation of the offer. 4 November 2015
Generics
Drug maker Cipla said it has agreed to sell its entire stake in Biomab Holding for almost $26 million. 30 October 2015
Generics
IGI Laboratories, a New Jersey, USA-based specialty generic pharmaceutical company, has entered into an agreement to acquire the assets of Alveda Pharmaceuticals. 13 October 2015
Generics
New Jersey-based specialty generic company IGI Laboratories say it has acquired three currently marketed injectable products from privately-held US biotech firm Concordia Pharmaceuticals for $10 million in cash. 6 October 2015
Generics
Pharmaceutical companies Ireland-headquartered Endo International (Nasdaq: ENDP) and privately-held Par Pharmaceutical have agreed to divest all of Endo’s rights and assets to generic glycopyrrolate tablets and generic methimazole tablets in order to settle US Federal Trade Commission charges that the proposed $8 billion acquisition (The Pharma Letter June 18) would be anticompetitive. 28 September 2015
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze